首页> 美国卫生研究院文献>AMIA Annual Symposium Proceedings >Using Workflow Modeling to Identify Areas to Improve Genetic Test Processes in the University of Maryland Translational Pharmacogenomics Project
【2h】

Using Workflow Modeling to Identify Areas to Improve Genetic Test Processes in the University of Maryland Translational Pharmacogenomics Project

机译:在马里兰大学转化药物基因组学项目中使用工作流建模来识别区域以改善基因测试过程

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Delivering genetic test results to clinicians is a complex process. It involves many actors and multiple steps, requiring all of these to work together in order to create an optimal course of treatment for the patient. We used information gained from focus groups in order to illustrate the current process of delivering genetic test results to clinicians. We propose a business process model and notation (BPMN) representation of this process for a Translational Pharmacogenomics Project being implemented at the University of Maryland Medical Center, so that personalized medicine program implementers can identify areas to improve genetic testing processes. We found that the current process could be improved to reduce input errors, better inform and notify clinicians about the implications of certain genetic tests, and make results more easily understood. We demonstrate our use of BPMN to improve this important clinical process for CYP2C19 genetic testing in patients undergoing invasive treatment of coronary heart disease.
机译:向临床医生提供基因检测结果是一个复杂的过程。它涉及许多参与者和多个步骤,需要所有这些参与者共同努力才能为患者创造最佳治疗方案。我们使用从焦点小组获得的信息来说明将基因检测结果提供给临床医生的当前过程。我们为马里兰大学医学中心正在实施的转化药物基因组学项目提出了一个业务流程模型和此流程的表示法(BPMN),以便个性化医学计划实施者可以确定需要改进基因测试流程的领域。我们发现可以改进当前流程以减少输入错误,更好地告知和通知临床医生某些基因检测的含义,并使结果更容易理解。我们证明了我们使用BPMN来改善进行冠心病侵入性治疗的患者中CYP2C19基因测试的这一重要临床过程。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号